@article{7a35287ae31744848507200d79d99d16,
title = "Treatment of focal dystonias with botulinum neurotoxin",
abstract = "This is a review on the use of injections of botulinum toxin for the treatment of focal dystonias. Disorders covered include cranial dystonia, cervical dystonia, spasmodic dysphonia, and focal hand dystonia. Considered are clinical aspects, alternative treatment strategies and principles of use of botulinum toxin injections.",
keywords = "Botulinum toxin, Cervical dystonia, Cranial dystonia, Focal dystonia, Focal hand dystonia, Spasmodic dysphonia",
author = "Mark Hallett and Reiner Benecke and Andrew Blitzer and Comella, {Cynthia L.}",
note = "Funding Information: Dr. Hallett is the Chair of the Neurotoxin Institute Advisory Board, an educational organization. His funding comes from the Intramural Research Program of the National Institute of Neurological Disorders and Stroke. Dr. Benecke declares no conflicts. Dr. Blitzer has research funding from or is a consultant for Allergan, Inc., Merz, Inc., Revance, Myotech, Iridex lasers, and Xomed/Medronics. Dr. Comella is a consultant for Allergan, Boehringer Ingelheim, Cephalon., Merz, Valeant, UCB, and received research support from Allergan, Ipsen, Solstice, Merz, Boehirnger, Solvay, Parkinson Study Group, and NIH.",
year = "2009",
month = oct,
doi = "10.1016/j.toxicon.2008.12.008",
language = "English",
volume = "54",
pages = "628--633",
journal = "Toxicon",
issn = "0041-0101",
publisher = "Elsevier Ltd.",
number = "5",
}